Skip to main content

Dorsal BNST α-adrenergic receptors produce HCN-dependent excitatory actions that initiate anxiogenic behaviors


AUTHORS

Harris NANicholas A , Isaac ATAustin T , Günther AAnne , Merkel KKevin , Melchior JJames , Xu MMichelle , Eguakun EEghosa , Perez RRafael , Nabit BPBrett P , Flavin SStephanie , Gilsbach RRalf , Shonesy BBrian , Hein LLutz , Abel TTed , Baumann AArnd , Matthews RRobert , Centanni SWSamuel W , Winder DGDanny G . The Journal of neuroscience : the official journal of the Society for Neuroscience. 2018 08 27; ().

ABSTRACT

Stress is a precipitating agent in neuropsychiatric disease and initiates relapse to drug-seeking behavior in addicted patients. Targeting the stress system in protracted abstinence from drugs of abuse with anxiolytics may be an effective treatment modality for substance use disorders. α-adrenergic receptors (α-ARs) in extended amygdala structures play key roles in dampening stress responses. Contrary to early thinking, α-ARs are expressed at non-noradrenergic sites in the brain. These non-noradrenergic α-ARs play important roles in stress-responses, but their cellular mechanisms of action are unclear. In humans, the α-AR agonist guanfacine reduces overall craving and uncouples craving from stress yet minimally affects relapse, potentially due to competing actions in the brain. Here we show that heteroceptor α-ARs postsynaptically enhance dorsal BNST (dBNST) neuronal activity in mice of both sexes. This effect is mediated by hyperpolarization-activated cyclic nucleotide-gated cation (HCN) channels, as inhibition of these channels is necessary and sufficient for excitatory actions. Finally, this excitatory action is mimicked by clozapine-N-oxide activation of the G-coupled DREADD hM4Di in dBNST neurons, and its activation elicits anxiety-like behavior in the elevated plus maze. Together, this data provides a framework for elucidating cell-specific actions of GPCR signaling and provides a potential mechanism whereby competing anxiogenic and anxiolytic actions of guanfacine may affect its clinical utility in the treatment of addiction.Stress impacts the development of neuropsychiatric disorders including anxiety and addiction. Guanfacine is an α-adrenergic receptor (α-AR) agonist with actions in the bed nucleus of the stria terminalis (BNST) that produces antidepressant actions and uncouples stress from reward-related behaviors. Here we show that guanfacine increases dBNST neuronal activity through actions at postsynaptic α-ARs via a mechanism that involves hyperpolarization-activated cyclic nucleotide gated cation (HCN) channels. This action is mimicked by activation of the designer receptor hM4Di expressed in the BNST, which also induces anxiety-like behaviors. Together, these data suggest 1) that postsynaptic α-ARs in BNST have excitatory actions on BNST neurons, and 2) these actions can be phenocopied by the so-called “inhibitory” DREADDs, suggesting care must be taken regarding interpretation of data obtained with these tools.